Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cost-related medication nonadherence after implementation of Medicare Part D, 2006-2007.

Literature DB >> 19861666

Cost-related medication nonadherence after implementation of Medicare Part D, 2006-2007.

Jeanne M Madden¹, Amy J Graves, Dennis Ross-Degnan, Becky A Briesacher, Stephen B Soumerai.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Year: 2009 PMID： 19861666 PMCID： PMC3770299 DOI： 10.1001/jama.2009.1516

Source DB: PubMed Journal: JAMA ISSN： 0098-7484 Impact factor: 56.272

× No keyword cloud information.

2 in total

1. Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit.

Authors: Stephen B Soumerai; Marsha Pierre-Jacques; Fang Zhang; Dennis Ross-Degnan; Alyce S Adams; Jerry Gurwitz; Gerald Adler; Dana Gelb Safran
Journal: Arch Intern Med Date: 2006-09-25

Review 2. Patients at-risk for cost-related medication nonadherence: a review of the literature.

Authors: Becky A Briesacher; Jerry H Gurwitz; Stephen B Soumerai
Journal: J Gen Intern Med Date: 2007-04-05 Impact factor: 5.128

2 in total

24 in total

1. The doughnut hole: it's about medication adherence.

Authors: Christianne L Roumie
Journal: Ann Intern Med Date: 2012-06-05 Impact factor: 25.391

2. Is Optimal Medical Therapy as Used in the COURAGE Trial Feasible for Widespread Use?

Authors: David J Maron; William E Boden; William S Weintraub; Karen J Calfas; Robert A O'Rourke
Journal: Curr Treat Options Cardiovasc Med Date: 2011-02

3. Use of prescription drug samples and patient assistance programs, and the role of doctor-patient communication.

Authors: Walid F Gellad; Haiden A Huskamp; Angela Li; Yuting Zhang; Dana Gelb Safran; Julie M Donohue
Journal: J Gen Intern Med Date: 2011-07-13 Impact factor: 5.128

4. Potential savings associated with drug substitution in Medicare Part D: the Translating Research into Action for Diabetes (TRIAD) study.

Authors: O Kenrik Duru; Susan L Ettner; Norman Turk; Carol M Mangione; Arleen F Brown; Jeffery Fu; Leslie Simien; Chien-Wen Tseng
Journal: J Gen Intern Med Date: 2013-08-22 Impact factor: 5.128

5. Pharmacy accessibility and cost-related underuse of prescription medications in low-income Black and Hispanic urban communities.

Authors: Dima Mazen Qato; Jocelyn Wilder; Shannon Zenk; Andrew Davis; Jennifer Makelarski; Stacy Tessler Lindau
Journal: J Am Pharm Assoc (2003) Date: 2017-01-30

6. Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trial.

Authors: Daniel H Solomon; Maura D Iversen; Jerry Avorn; Timothy Gleeson; M Alan Brookhart; Amanda R Patrick; Laura Rekedal; William H Shrank; Joyce Lii; Elena Losina; Jeffrey N Katz
Journal: Arch Intern Med Date: 2012-02-27

Cost-related medication nonadherence after implementation of Medicare Part D, 2006-2007.

1. Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit.

Review 2. Patients at-risk for cost-related medication nonadherence: a review of the literature.

1. The doughnut hole: it's about medication adherence.

2. Is Optimal Medical Therapy as Used in the COURAGE Trial Feasible for Widespread Use?

3. Use of prescription drug samples and patient assistance programs, and the role of doctor-patient communication.

4. Potential savings associated with drug substitution in Medicare Part D: the Translating Research into Action for Diabetes (TRIAD) study.

5. Pharmacy accessibility and cost-related underuse of prescription medications in low-income Black and Hispanic urban communities.

6. Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trial.

7. Persistent medication affordability problems among disabled Medicare beneficiaries after Part D, 2006-2011.

8. Cost-related nonadherence by medication type among Medicare Part D beneficiaries with diabetes.

9. Cost-related medication nonadherence in older patients with rheumatoid arthritis.

10. Medication affordability gains following Medicare Part D are eroding among elderly with multiple chronic conditions.